Diagnostic, endocrinological, behavioral, and DNA ploidy differences between squamous cell and adenomatous carcinoma of the cervix uteri

Oncology Research

Volumn 14, Issue 7-8, 2004, Pages 321-324

  Lindström, Annika Kristina ^a,b,e   Hellberg, Dan ^c,d   Bäckström, Torbjörn ^b   Stendahl, Ulf ^b  

^a Ventrum Clinic   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c FALUN HOSPITAL   (Sweden)

^d Centre for Clinical Research   (Sweden)

^e NONE   (Sweden)

Author keywords

Adenocarcinoma; Cervix neoplasms; Squamous cell carcinoma

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER GROWTH; CANCER RISK; ESTRADIOL BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PLOIDY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA;

EID: 4043128913     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/0965040041292314     Document Type: Article

References (12)

1. Hemminki, K.; Li, X.; Vaittinen, P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996. Eur. J. Obstet. Gynecol. Reprod. Biol. 101:64-69; 2002.
2. Altekruse, S. F.; Lacey, J. V., Jr.; Brinton, L. A.; Gravitt, P. E.; Silverberg, S. G.; Barnes, W. A., Jr.; Greenberg, M. D.; Hadjimichael, O. C; McGowan, L.; Mortel, R.; Schwartz, P. E.; Hildesheim, A. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am. J. Obstet. Gynecol. 188:657-663; 2003.
3. Waggoner, S. E. Cervical cancer. Lancet 361:2217-2225; 2003.
4. Lindström, A.; Bäckström, T.; Hellberg, D.; Tribukait, B.; Strang, P.; Stendahl, U. Correlations between serum progesterone and smoking, and the growth fraction of cervical squamous cell carcinoma. Anticancer Res. 20:1-4; 2000.
5. Lacey, J. V., Jr.; Brinton, L. A.; Abbas, F. M.; Barnes, W. A.; Gravitt, P. E.; Greenberg. M. D.; Greene, S. M., Hadjimichael. O. C.; McGowan, L.; Mortel. R.; Schwartz, P. E.; Silverberg, S. G.; Hildesheim, A. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev. 8:1079-1085; 1999.
6. Honore, L. H.; Koch, M.; Brown, L. B. Comparison of oral contraceptive use in women with adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol. Obstet. Invest. 32:98-101; 1991.
7. Lacey, J. V.; Frisch, M.; Brinton, L. A.; Abbas, F. M.; Barnes, W. A.; Gravitt, P. E.; Greenberg, M. D.; Greene, S. M.; Hadjimichael, O. C.; McGowan, L.; Mortel, R.; Schwartz, P. E.; Zaino, R. J.; Hildesheim. A. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12:153-161; 2001.
8. Hellberg, D.; Nilsson, S.; Haley, N. J.; Hoffman, D.; Wynder, E. Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am. J. Obstet. Gynecol. 158: 910-913; 1988.
9. v. Knebel Doeberitz, M.; Spitkovsky, D.; Ridder, R. Interactions between steroid hormones and viral oncogenes in the pathogenesis of cervical cancer. Verh. Dtsch. Ges. Pathol. 81:233-239; 1997.
10. Webster, K.; Taylor, A.; Gaston, K. Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J. Genet. Virol. 82:201-213; 2001.
11. Yuan, F.; Auborn, K.; James, C. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone. Cancer Invest. 17:19-29; 1999.
12. Thomas, D. B.; Ray, R. M.; the WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. Am. J. Epidemiol. 144: 281-289; 1996.